Zydus receives approval from the US drug authority to produce cholesterol-lowering tablets

Apr 30, 2025

Zydus Lifesciences Limited, has received final approval from the United States Food and Drug Administration (USFDA) to manufacture Niacin Extended-Release Tablets.

Zydus Cadila receives final approval from USFDA for Glycopyrrolate injection

Nov 10, 2021

Ahmedabad (Gujarat) [India], November 10 : India-based pharma giant, Zydus Cadila received final approval from USFDA for Glycopyrrolate injection that is used before surgery...

Zydus receives final approval from USFDA to market Colestipol Hydrochloride tablets

Mar 14, 2022

Ahmedabad (Gujarat) [India], March 15 : Zydus Lifesciences Ltd. has received final approval from the United States Food and Drug Administration (USFDA) to market...

Cipla secures USFDA approval for pancreatic disease injection, shares surge

May 22, 2024

Mumbai-headquartered pharma major, Cipla's US arm has secured final approval from the United States Food and Drug Administration (USFDA) for its Lanreotide Injection 120...

Zydus receives final approval from USFDA to market drug used to relieve chest pain

Mar 09, 2022

New Delhi [India], March 9 : Zydus Lifesciences Ltd. has received final approval from the United States Food and Drug Administration (USFDA) to market...

Granules India subsidiary clears USFDA audit

Jul 21, 2021

Hyderabad (Telangana) [India], July 21 : The drug maker Granules India on Wednesday announced that its US-based subsidiary cleared a pre-approval inspection (PAI) audit...